 Navin Fluorine International Ltd approves capex
Navin Fluorine International Ltd approves capex Purest gold, silver products in 10 minutes: MMTC-PAMP partners with Swiggy Instamart
Purest gold, silver products in 10 minutes: MMTC-PAMP partners with Swiggy Instamart Cosmo Plastech Expands Rigid Packaging Solutions for the Pharmaceutical Industry with PET Sheets
Cosmo Plastech Expands Rigid Packaging Solutions for the Pharmaceutical Industry with PET Sheets IPO Note - Lenskart Solutions Ltd - Reliance Securities
IPO Note - Lenskart Solutions Ltd - Reliance Securities IndiGo expands its Middle East footprint with new Bengaluru-Riyadh direct flights, starting 16 November 2025
IndiGo expands its Middle East footprint with new Bengaluru-Riyadh direct flights, starting 16 November 2025 
              The Board of Directors of Krebs Biochemicals & Industries Ltd at its meeting held on Monday, 25th March 2019 has approved the allotment of 28,86,300 equity shares as per the basis of allotment approved by BSE Limited (the Designated Stock Exchange) on 22nd March 2019. Further, the paid-up equity share capital of the Company amounts to Rs. 16,63,05,860/- divided into 1,66,30,586 equity shares of Rs. 10/- each.
Shares of KREBS BIOCHEMICALS & INDUSTRIES LTD. was last trading in BSE at Rs.93.25 as compared to the previous close of Rs. 94.4. The total number of shares traded during the day was 526 in over 10 trades.
The stock hit an intraday high of Rs. 96.5 and intraday low of 93. The net turnover during the day was Rs. 49581.